You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells

Article metrics

Article menu

Download PDFPDF

Research Article
Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells

 

Online download statistics by month:

Online download statistics by month: December 2019 to January 2026

AbstractFullPdf
Dec 2019220
Jan 202015150
Feb 202048486
Mar 202044447
Apr 2020313113
May 2020525220
Jun 202021212
Jul 202029293
Aug 202020204
Sep 202038386
Oct 2020434321
Nov 2020262611
Dec 202023237
Jan 2021323221
Feb 2021404016
Mar 202148489
Apr 2021434315
May 2021282815
Jun 202138383
Jul 202122226
Aug 2021333312
Sep 2021333313
Oct 2021292918
Nov 2021474725
Dec 2021313110
Jan 2022414210
Feb 2022313816
Mar 2022444523
Apr 2022414322
May 2022546130
Jun 2022475722
Jul 2022353611
Aug 2022666721
Sep 2022133134111
Oct 2022606114
Nov 2022404229
Dec 2022404015
Jan 2023384110
Feb 2023657117
Mar 2023636720
Apr 2023283217
May 2023353813
Jun 2023585915
Jul 2023464614
Aug 2023676818
Sep 20231671689
Oct 2023929412
Nov 202318718717
Dec 202316216220
Jan 202410510615
Feb 2024596023
Mar 2024687118
Apr 2024717324
May 20241571578
Jun 2024575812
Jul 2024899012
Aug 2024434318
Sep 2024495013
Oct 2024494932
Nov 2024798022
Dec 2024778018
Jan 2025717130
Feb 2025616117
Mar 2025999943
Apr 2025999934
May 2025626225
Jun 2025505022
Jan 2026110
Total380238751155